Raymond James & Associates grew its holdings in shares of Clarivate Plc (NYSE:CLVT – Free Report) by 19.0% in the second quarter, according to its most recent filing with the SEC. The firm owned 7,244,790 shares of the company’s stock after acquiring an additional 1,157,976 shares during the quarter. Raymond James & Associates owned about 1.08% of Clarivate worth $41,223,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Evermay Wealth Management LLC acquired a new stake in Clarivate in the first quarter worth about $31,000. Montag A & Associates Inc. boosted its holdings in shares of Clarivate by 729.6% in the fourth quarter. Montag A & Associates Inc. now owns 7,732 shares of the company’s stock valued at $72,000 after acquiring an additional 6,800 shares in the last quarter. J.W. Cole Advisors Inc. acquired a new position in shares of Clarivate during the first quarter valued at approximately $76,000. Transcend Capital Advisors LLC bought a new stake in Clarivate during the second quarter worth approximately $86,000. Finally, TFO Wealth Partners LLC raised its holdings in Clarivate by 1,590,000.0% during the fourth quarter. TFO Wealth Partners LLC now owns 15,901 shares of the company’s stock worth $147,000 after purchasing an additional 15,900 shares in the last quarter. Institutional investors own 85.72% of the company’s stock.
Clarivate Trading Up 0.9 %
Shares of NYSE CLVT opened at $6.41 on Tuesday. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 1.03. Clarivate Plc has a 12 month low of $4.97 and a 12 month high of $9.60. The company has a market cap of $4.28 billion, a price-to-earnings ratio of -3.86, a P/E/G ratio of 4.38 and a beta of 1.15. The business has a fifty day simple moving average of $5.94 and a 200-day simple moving average of $6.76.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the company. Barclays lowered their price target on Clarivate from $6.00 to $5.00 and set an “underweight” rating on the stock in a research report on Wednesday, August 7th. Royal Bank of Canada lowered their target price on Clarivate from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Wednesday, August 7th. Finally, The Goldman Sachs Group dropped their price target on shares of Clarivate from $8.50 to $7.50 and set a “buy” rating on the stock in a research report on Thursday, May 9th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Clarivate has an average rating of “Hold” and a consensus price target of $7.75.
View Our Latest Stock Analysis on CLVT
Insider Activity at Clarivate
In other Clarivate news, Director Andrew Miles Snyder bought 28,938 shares of the firm’s stock in a transaction dated Thursday, August 8th. The stock was acquired at an average price of $5.49 per share, with a total value of $158,869.62. Following the completion of the transaction, the director now directly owns 288,334 shares in the company, valued at approximately $1,582,953.66. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 22.77% of the stock is owned by insiders.
About Clarivate
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Recommended Stories
- Five stocks we like better than Clarivate
- Ride Out The Recession With These Dividend KingsĀ
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- What is Insider Trading? What You Can Learn from Insider Trading
- 2 Option Strategies to Maximize Profits in a Bear Market
- Insider Trades May Not Tell You What You Think
- Lululemon Stock Gears Up for a Massive Comeback Rally
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVT – Free Report).
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.